Ignite Creation Date:
2024-05-06 @ 3:44 PM
Last Modification Date:
2024-10-26 @ 1:55 PM
Study NCT ID:
NCT04734210
Status:
COMPLETED
Last Update Posted:
2023-10-06
First Post:
2021-01-28
Brief Title:
Research Study To See How Well An Eye Drop SURF-200 Works What Side Effects There Are And To Compare It With Vehicle In Subjects With An Episodic Flare-Up of Dry Eye Disease
Sponsor:
Surface Ophthalmics Inc
Organization:
Surface Ophthalmics Inc
Study Overview
Official Title:
A Multicenter Randomized Double-Masked Dose-Ranging Study To Compare The Ocular Safety Tolerability And Efficacy Of SURF-200 Ophthalmic Solution 002 And 004 Betamethasone Sodium Phosphate To Vehicle In Subjects With A Diagnosis Of Dry Eye Disease And Experiencing An Episodic Flare Up
Status:
COMPLETED
Status Verified Date:
2023-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
SURF-200 is being studied in people experiencing an episodic flare-up of their dry eye disease SURF-200 is an investigational drug which means the study drug is currently being tested in the form of a sterile eye drop
The purpose of this research study is to see how well SURF-200 works and what side effects there are and to compare it with vehicle placebo The study will involve about 120 study participants at multiple research sites in the United States
The purpose of this research study is to see how well SURF-200 works and what side effects there are and to compare it with vehicle placebo The study will involve about 120 study participants at multiple research sites in the United States
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None